IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $252,250 | +1.7% | 25,000 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $248,000 | +1.2% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $245,000 | 0.0% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $245,000 | +0.8% | 25,000 | 0.0% | 0.00% | – |
| Q4 2021 | $243,000 | +0.4% | 25,000 | 0.0% | 0.00% | – |
| Q3 2021 | $242,000 | 0.0% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $242,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |